BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 28, 2015
View Archived Issues
ChemoCentryx, a company focusing on chemoattractant receptors, reviews company outlook
Read More
Novel synthetic medium-size compounds mimic functions of antibodies
Read More
New evidence provided on SEMA4D as a promising target for MS
Read More
3SBio acquires contract manufacturer Sirton Pharmaceuticals
Read More
PXT-864 pleodrug improves biological AD-related features
Read More
RestorGenex compound granted FDA orphan status for glioblastoma multiforme
Read More
Aclaris Therapeutics reports data from phase IIb trial of A-101
Read More
Actavis to acquire Auden Mckenzie
Read More
Hybrigenics extends partnership with Servier for ubiquitin-specific protease inhibitors
Read More
Pfizer aims to improve access to Prevenar 13 in poorest countries
Read More
Redx Pharma patents Hedgehog signaling pathway inhibitors
Read More
Takeda reports development of RORgamma-t antagonists
Read More
Anti-IL-32 MAbs described in ImmunoQure patent
Read More
Academic researchers prepare and test ALK inhibitors
Read More
Abide Therapeutics divulges MGL inhibitors
Read More
National University of Singapore presents peptide inhibitors of FXI
Read More
NRX-1074 improves depression scores in phase I study
Read More
CF-602 shows promise for sexual dysfunction in preclinical studies
Read More
Cutanea Life Sciences initiates phase II trial of CLS-003 for cutaneous warts
Read More
PlantForm initiates financing round to fund development of biosimilars
Read More
Boehringer Ingelheim studies effect of tiotropium and olodaterol Respimat on COPD exacerbations
Read More
Forest initiates pediatric phase I/II trial of ceftaroline fosamil
Read More
Radius Health initiates phase I trial of RAD-1901 in breast cancer
Read More
Amgen and Onyx file applications to expand approval of carfilzomib in the E.U. and U.S.
Read More
Janssen closes collaboration and license agreement with MacroGenics for MGD-011
Read More